Shigella flexneri serotype identification primer group and application
Through the LAMP technology-based serotype primer composition of Shigella Fukuro, the problem of expensive equipment and complex operation in the prior art is solved, and the rapid and accurate identification of all 19 serotypes of Shigella Fukuro, with High sensitivity and specificity, suitable for use in basic laboratories.
Patent Information
- Application Number
- CN202411177876.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-22
AI Technical Summary
The existing Shigella Fukuro serotype identification methods have problems such as expensive equipment, complex operation, subjective result judgment, and time consumption, which limits the rapid, accurate and specific detection capabilities of grassroots disease control departments.
The primer composition based on LAMP technology was used to design LAMP primers for detecting Shigella Fukuro's gtrI, gtrIc, oac, gtrIV, gtrV and oacC genes, combined with the gtrII, gtrX and opt genes in the ZL2021107109927 patent to form 9 sets of primers Combined to achieve rapid identification of all 19 serotypes of Shigella Fukura.
It realizes the simple operation, fast and efficient serotype identification of Shigella Fukura, with a sensitivity of more than 10 pg/μl, high specificity, no expensive equipment required, and can quickly and accurately detect all 19 serotypes, which is suitable for use in grassroots laboratories.
Smart Images

Figure CN118995970A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of pathogen molecular identification, and in particular to a primer composition for Shigella flexneri serotype identification based on LAMP technology and an application of the primer composition in rapid detection of all 19 serotypes of Shigella flexneri. Background Art
[0002] Shigella is the pathogen of bacillary dysentery in humans, and its morbidity and mortality rate are the highest among infectious diarrheal diseases. It is estimated that about 89.6% of Shigella infections worldwide are caused by Shigella flexneri and Shigella sonnei (Wang XY, Tao F, Xiao D, Lee H, Deen J, Gong J, Zhao Y, Zhou W, Li W, Shen B et al: Trend and disease burden of bacillary dysentery in China (1991-2000). Bulletin of the World Health Organization 2006, 84(7):561-568.). Shigella flexneri and Shigella sonnei are the main types of Shigella prevalent in my country. According to the statistical data from 1991 to 2000, the main Shigella prevalent in my country was Shigella flexneri, accounting for 86%, of which the dominant serotype was 2a, accounting for 80% of the flexneri isolates; Shigella sonnei accounted for 12% (YeC, Lan R, Xia S, Zhang J, Sun Q, Zhang S, Jing H, Wang L, Li Z, Zhou Z et al: Emergence of a new multidrug-resistant serotype X variant in an epidemic clone of Shigella flexneri. Journal of clinical microbiology 2010, 48(2):419-426.). A nationwide sentinel hospital-based surveillance data from 2003 to 2013 showed that among the 2912 Shigella strains isolated, 1610 were Shigella flexneri and 1284 were Shigella sonnei (Qiu S, Xu X, Yang C, Wang J, Liang B, Li P, Li H, Yi S, Liu H, Cui X et al: Shift in serotype distribution of Shigella species in China, 2003-2013. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21(3):252 e255-268.).Among the 474 Shigella isolated in Shanxi Province between 2006 and 2016, 337 strains were Shigella flexneri (71%) and 137 strains were Shigella sonnei (29%). There were 6 serotypes of Shigella flexneri isolated, including 1a, 1b, 2a, 2b, Xv and 5b. Among them, Xv and 1a were the dominant serotypes, accounting for 43% and 30% respectively (WANGY, MA Q, HAO R, et al. Antimicrobial resistance and genetic characterization of Shigella spp. in Shanxi Province, China, during 2006-2016 [J]. BMCmicrobiology, 2019, 19(1): 116.).
[0003] The traditional method for identifying the serotype of Shigella flexneri mainly uses commercial diagnostic antisera to agglutinate the strain on a glass slide, and makes a judgment based on the immunoagglutination results. Commercial serum is expensive, and some new serotypes require monoclonal antibodies for auxiliary identification (such as the Xv serotype requires group-specific antisera 7 and 8 and monoclonal antibody MASF Ⅳ-1 for combined judgment). It is not easy for grassroots disease control departments to obtain it, which limits its application. In addition, the results of serum agglutination reactions are affected by bacterial culture conditions and growth status, and the results are greatly affected by subjective factors. The operation is time-consuming and labor-intensive, and it does not meet the requirements of rapidity, accuracy, and specificity.
[0004] The prior art has established common PCR and fluorescence quantitative PCR methods for distinguishing and identifying serotypes of Shigella flexneri and Shigella sonnei based on the serotype-related genes of Shigella flexneri. The diversity of Shigella flexneri serotypes is determined by type-specific antigenic determinants (such as IV and IC) and group-specific antigenic determinants (such as 3, 4; 6; and 7, 8). According to the O-antigen modification of Shigella flexneri serotype Xv and its production mechanism, specific primers are designed for type-specific and group-specific antigenic determinants, and a multiplex PCR system is designed to detect serotypes (Sun, Q.; Lan, R.; Wang, Y.; Zhao, A.; Zhang, S.; Wang, J.; Wang, Y.; Xia, S.; Jin, D.; Cui, Z. Development of a MultiplexPCR Assay Targeting O-Antigen Modification Genes for Molecular Serotyping ofShigella flexneri. Journal of clinical microbiology 2011, 49, 3766-3770.). In addition to the multiplex PCR method, a fluorescence quantitative PCR method was also designed based on the serotype-specific antigenic determinant cluster and group-specific antigenic determinant cluster genes of Shigella flexneri (Gentle, A.; Ashton, PM; Dallman, TJ; Jenkins, C. Evaluation of Molecular Methods for Serotyping Shigella flexneri. Journal of clinical microbiology 2016, 54, JCM.03386-03315.), and commercial reagents are available. However, these methods have high requirements for reaction reagents. The PCR reaction takes about 2 hours, and gel electrophoresis is required for result interpretation. The fluorescence quantitative PCR system requires multiple multiple reactions to be carried out simultaneously to detect serotypes. The result interpretation is complicated, the reagent price is high, and the method requires large instruments such as fluorescence quantitative PCR, which is not conducive to grassroots promotion and use.
[0005] In addition, there is a genome-based method for identifying the serotype of Shigella flexneri. By analyzing the genome sequence of Shigella flexneri and obtaining the gene sequence of the serotype-related genes in the genome sequence of Shigella flexneri, the corresponding serotype of Shigella flexneri can be obtained (Gentle, A.; Ashton, PM; Dallman, TJ; Jenkins, C. Evaluation of Molecular Methods for Serotyping Shigella flexneri. Journal ofclinical microbiology 2016, 54, JCM.03386-03315.). Whole genome sequence analysis can accurately analyze the serotype-determining genes of Shigella flexneri, but whole genome sequence analysis requires bioinformatics analysis capabilities, which limits its application in grassroots laboratories. In addition, grassroots laboratories usually find it difficult to perform whole genome sequence analysis on all strains, and the time limit for whole genome sequence analysis is relatively long.
[0006] In view of this, the present invention is proposed. Summary of the invention
[0007] In order to solve the above technical problems, the present invention provides a primer composition for identifying Shigella flexneri serotypes based on LAMP technology and its application in rapid detection of all 19 serotypes of Shigella flexneri.
[0008] Specifically, the technical solution of the present invention is as follows: In a first aspect, the present invention provides a LAMP primer set for detecting serotypes of Shigella flexneri, including a primer set for detecting Shigella flexneri gtrⅠ , gtrⅠc , oac , gtrⅣ , gtrⅤ and oacC LAMP primers for genes,
[0009] For detection of Shigella flexneri gtrⅠ LAMP primers for genes include gtrⅠ -F3, gtrⅠ -B3, gtrⅠ -FIP and gtr Ⅰ -BIP, the nucleotide sequences are shown in SEQ ID NO.01-04; For detection of Shigella flexneri gtrⅠc LAMP primers for genes include gtrⅠc -F3, gtrI-B3, gtrⅠc -FIP and gtrⅠc-BIP, the nucleotide sequences of which are shown in SEQ ID NOs. 07 to 10; For detection of Shigella flexneri oac LAMP primers for genes include oac -F3, oac -B3, oac -FIP and oac -BIP, the nucleotide sequences of which are shown in SEQ ID NOs. 18 to 21; For detection of Shigella flexneri gtrⅣ LAMP primers for genes include gtrⅣ -F3, gtrⅣ -B3, gtrⅣ -FIP and gtrⅣ -BIP, the nucleotide sequences of which are shown in SEQ ID NOs. 24 to 27; For detection of Shigella flexneri gtrⅤ LAMP primers for genes include gtrⅤ -F3, gtrⅤ -B3, gtrⅤ -FIP and gtrⅤ -BIP, the nucleotide sequences of which are shown in SEQ ID NOs. 29 to 32; For detection of Shigella flexneri oacC LAMP primers for genes include oacC -F3, oacC -B3, oacC -FIP and oacC -BIP, whose nucleotide sequences are shown in SEQ ID NOs.45-48.
[0010] Preferably, for detecting Shigella flexneri gtrⅠ LAMP primers for genes also include: loop primers gtrⅠ -LF and gtr Ⅰ -LB, whose nucleotide sequences are shown in SEQ ID NO.5-6; and / or, for detection of Shigella flexneri gtrⅠc LAMP primers for genes also include: loop primers gtrⅠc -LF, the nucleotide sequence of which is shown in SEQ ID NO.11; and / or, for detection of Shigella flexneri oac LAMP primers for genes also include: loop primers oac -LF and loop primers oac -LB, the nucleotide sequences of which are shown in SEQ ID NOs. 22-23; and / or, for detection of Shigella flexneri gtrⅣLAMP primers for genes also include: loop primers gtrⅣ -LF, the nucleotide sequence of which is shown in SEQ ID NO.28; and / or, for detection of Shigella flexneri gtrⅤ LAMP primers for genes also include: gtrⅤ -LF and gtrⅤ -LB, whose nucleotide sequences are shown in SEQ ID NO.33-34; and / or, for detection of Shigella flexneri oacC LAMP primers for genes also include: oacC -LF, the nucleotide sequence of which is shown in SEQ ID NO.49.
[0011] Preferably, the LAMP primer set also includes a primer for detecting Shigella flexneri gtrII , gtrX and opt LAMP primers for genes,
[0012] For detection of Shigella flexneri gtrII LAMP primers for genes include gtrII -F3, gtrII -B3, gtrII -FIP and gtrII -BIP, the nucleotide sequences are shown in SEQ ID NOs. 12 to 15; For detection of Shigella flexneri gtrX LAMP primers for genes include gtrX -F3, gtrX -B3, gtrX -FIP and gtrX -BIP, the nucleotide sequences are shown in SEQ ID NOs. 35 to 38; For detection of Shigella flexneri opt LAMP primers for genes include opt -F3, opt -B3, opt -FIP and opt -BIP, the nucleotide sequences are shown in SEQ ID NOs. 40 to 43.
[0013] Preferably, for detecting Shigella flexneri gtrII LAMP primers for genes also include: loop primers gtrII -LF and gtrII -LB, the nucleotide sequences of which are shown in SEQ ID NOs. 16-17; and / or, for detection of Shigella flexneri gtrX LAMP primers for genes also include: loop primers gtrX-LF, the nucleotide sequence of which is shown in SEQ ID NO.39; and / or, for detection of Shigella flexneri opt LAMP primers for genes also include: loop primers opt -LB, the nucleotide sequence of which is shown in SEQ ID NO.44.
[0014] In a second aspect, the present invention provides a detection reagent or a kit comprising the LAMP primer set.
[0015] In a third aspect, the present invention provides the use of the LAMP primer set, or a detection reagent or kit comprising the LAMP primer set in detecting Shigella flexneri serotypes, wherein the use is for non-disease diagnosis and treatment purposes.
[0016] In a fourth aspect, the present invention provides a method for detecting Shigella flexneri serotypes, comprising the following steps: 1) Extracting DNA from the sample to be tested; 2) using the DNA extracted in step 1) as a template, and performing a LAMP amplification reaction using the LAMP primer set according to any one of claims 1 to 4; 3) Determination of amplification results; The method is for non-disease diagnosis and treatment purposes.
[0017] Preferably, the LAMP amplification reaction system in step 2) is calculated as a 20 μL reaction system, including 10 μL 2X Bca BEST Buffer (Takara), primer mixture 1.5 μL (FIP and BIP primers 40 pmol, F3 and B3 primers 10 pmol, LF and / or LB primers 20 pmol), BcaBEST DNA Polymerase ver.2.0 (8U / μl) 0.4 μL, hydroxynaphthol blue (HNB dye) 2 μL and DNA template 2 μL, and finally make up to 20 μL with sterile water.
[0018] Preferably, the conditions of the LAMP amplification reaction in step 2) are 61° C., 40 min.
[0019] Preferably, step 3) uses any one of the following methods ① to ③ to determine the amplification result: ①Observe the color change with naked eyes: After the amplification reaction is completed, the amplification of the target gene is determined based on the color change of the reaction system before and after the reaction; ② Agarose gel electrophoresis: If the amplified product shows characteristic ladder-like bands on the agarose gel, it indicates that the sample to be tested contains the target gene; ③ Magnesium pyrophosphate turbidity detection method: Use a turbidity meter to detect its absorbance at 400nm. A turbidity greater than 0.1 is positive.
[0020] Beneficial effects: The present invention provides a primer combination for identifying Shigella flexneri serotypes based on LAMP technology and its application in rapid detection of all 19 serotypes of Shigella flexneri. The present invention designs an O antigen determinant gene ( gtrⅠ, gtrⅠ c, oac, gtrⅣ, gtrⅤ and oacC 6 sets of LAMP primers for genes) and the same as those in patent ZL2021107109927 gtrII, gtrX and opt The three sets of LAMP primers for the genes form nine sets of primers, which can accurately identify all 19 serotypes of Shigella flexneri. The present invention has the advantages of simple operation, rapidity and high efficiency, and does not require expensive equipment. After the reaction system is configured, the boiled template is added, and the result can be observed by naked eyes after incubation in a 61°C water bath for 40 minutes. The present invention has the advantages of high sensitivity and high specificity. gtrⅠ, gtrⅠc, oac, gtrⅣ, gtrⅤ and oacC The sensitivity of the six sets of LAMP primers to boiled Shigella flexneri template was greater than 10 pg / μl. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the drawings required for use in the embodiments or the description of the prior art will be described below.
[0022] Figure 1 The O antigen determinant gene in Example 1 of the present invention gtrⅠ , gtrⅠc , oac , gtrⅣ , gtrⅤ and oacC The sensitivity test results of different concentrations of boiled template reaction. Among them, Loopamp Real-time Turbidimeter LA-320C was used to monitor the turbidity of the reaction system, and the result was judged to be positive when the turbidity was greater than 0.1; CH1: template concentration 10ng / μL, CH2: template concentration 1ng / μL, CH3: template concentration 100pg / μL, CH4: template concentration 1pg / μL, CH5: template concentration 100fg / μL, CH6: template concentration 10fg / μL, CH7: template concentration 1fg / μL, CH8: blank control.
[0023] Figure 2 The O antigen determinant gene in Example 1 of the present invention gtrⅠcGene sensitivity reaction results. Among them, the color of the positive reaction tube is sky blue, and the color of the negative reaction tube is violet; tube 1: template concentration 10ng / μL, tube 2: template concentration 1ng / μL, tube 3: template concentration 100pg / μL, tube 4: template concentration 1pg / μL, tube 5: template concentration 100fg / μL, tube 6: template concentration 10fg / μL, tube 7: template concentration 1fg / μL, tube 8: blank control. DETAILED DESCRIPTION
[0024] The present invention designs the Shigella flexneri serotype determining gene according to the gtrⅠ , gtrⅠc , oac , gtrⅣ , gtrⅤ and oacC , LAMP primers for six genes, combined with the gtrII , gtrX and opt The present invention verifies the effectiveness of the above LAMP primer combination and detection system, and does not require expensive equipment and instruments, and can quickly, accurately and specifically detect all 19 serotypes of Shigella flexneri. The present invention also verifies the sensitivity and specificity of the LAMP detection system.
[0025] The LAMP primer information provided by the present invention is shown in Table 1.
[0026] Table 1 LAMP primer sequences
[0027] The conditions for LAMP amplification reaction were 61°C for 40 min.
[0028] Sensitivity: This method has 6 genes ( gtrⅠ , gtrⅠc , oac , gtrⅣ , gtrⅤ and oacC ) The sensitivity of the boiled Shigella flexneri template was greater than 10 pg / μl ( Figure 1 ), all 9 genes of Shigella flexneri serotype Y were negative. The detection results of 9 genes in 19 different serotypes of Shigella flexneri are shown in Table 2.
[0029] Table 2
[0030] Specificity: The test results were negative in 50 other Shigella strains, including 20 Shigella sonnei, 12 Shigella dysenteriae, and 18 Shigella boydii. The test results were negative in 46 other common intestinal bacteria, including 2 EAEC strains, 5 EHEC strains, 5 EIEC strains, 10 EPEC strains, 10 ETEC strains, 1 UPEC strain, 2 non-pathogenic Escherichia coli strains, 5 Listeria monocytogenes strains, 1 Vibrio parahaemolyticus strain, 4 Salmonella strains, and 1 Yersinia enterocolitica strain.
[0031] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0032] The endpoints and any values of the ranges disclosed in this specification are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and the individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.
[0033] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "specific implementations", or "some specific implementations" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the embodiment of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.
[0034] In the examples provided in this specification, if no specific techniques or conditions are specified, the techniques or conditions described in the literature in this field or the product instructions are used. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased through regular channels.
[0035] Example 1
[0036] (1) DNA template preparation
[0037] Prepare DNA template using boiling method. Take a single clone from an overnight cultured Shigella plate and place it in an eppendof tube containing 100 μL sterile water and shake to mix. Boil at 100°C for 10 minutes, place on ice for 5 minutes, centrifuge at 13,000 × for 10 minutes, and take the supernatant as the template.
[0038] (2) LAMP primer design
[0039] Use Primer Explorer V5 software to gtrⅠ , gtrⅠc , oac , gtrⅣ , gtrⅤ and oacC Primer design for the gene (https: / / primerexplorer.jp / v5_manual / index.html). LAMP primers include two pairs of inner primers (FIP and BIP) and two pairs of outer primers (F3 and B3). Loop primers (LF and / or LB) can be added to the reaction system to increase the specificity and speed of the LAMP reaction. The specificity of the primers was tested in the NCBI database using the BLAST method.
[0040] (3) LAMP reaction process
[0041] use Bca BEST ® DNA Polymerase ver.2.0 premix (Takara) was used for LAMP reaction. The LAMP reaction system was 20 μL, including 10 μL 2X Bca BEST Buffer, primer mixture 1.5 μL (FIP and BIP primers 40 pmol, F3 and B3 primers 10 pmol, LF and / or LB primers 20 pmol), BcaBEST DNA Polymerasever.2.0 (8 U / μl) 0.4 μL, hydroxynaphthol blue (HNB dye) 2 μL and DNA template 2 μL, and finally add sterile water to 20 μL. Incubate the mixed LAMP reaction tube at 61°C for 40 minutes. Observe the color change by naked eye. The positive reaction LAMP premix changes from violet to sky blue, while the negative reaction LAMP premix remains violet ( Figure 1 ).
[0042] (4) LAMP sensitivity evaluation
[0043] Sensitivity testing was performed using different serotypes of Shigella flexneri. The nucleic acid of Shigella flexneri was obtained by boiling, and the nucleic acid was quantified by Nanodrop ND-1000 instrument. The template concentration was adjusted to 10ng / μL, 1ng / μL, 100pg / μL, 1 pg / μL, 100 fg / μL, 10fg / μL and 1fg / μL using AE buffer (Qiagen), for a total of 7 concentrations. The LAMP reaction proved that the sensitivity of the six genes in this method to the boiled template of Shigella flexneri was higher than 10pg / μL ( Figure 1 ), the reaction time was less than 40 minutes.
[0044] The above results prove that the LAMP system provided by the present invention is sensitive and specific, does not require expensive equipment, is simple to operate, and is fast and efficient.
[0045] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. LAMP primer set for detecting Shigella flexneri serotypes, It is characterized in that Including detection of Shigella flexneri gtrⅠ , gtrIc , oac , gtrⅣ , gtrⅤ and oac LAMP primers for genes, For detection of Shigella flexneri gtrⅠ LAMP primers for genes include gtrⅠ -F3, gtrⅠ -B3, gtrⅠ -FIP and gtrⅠ -BIP, the nucleotide sequences are shown in SEQ ID NO.01-04; For detection of Shigella flexneri gtrIc LAMP primers for genes include gtrIc -F3, gtrI-B3, gtrIc -FIP and gtrⅠ c -BIP, the nucleotide sequences of which are shown in SEQ ID NOs. 07 to 10; For detection of Shigella flexneri oac LAMP primers for genes include oac -F3, oac -B3, oac -FIP and oac -BIP, the nucleotide sequences of which are shown in SEQ ID NOs. 18 to 21; For detection of Shigella flexneri gtrⅣ LAMP primers for genes include gtrⅣ -F3, gtrⅣ -B3, gtrⅣ -FIP and gtr Ⅳ -BIP, the nucleotide sequences of which are shown in SEQ ID NOs. 24 to 27; For detection of Shigella flexneri gtrⅤ LAMP primers for genes include gtrⅤ -F3, gtrⅤ -B3, gtrⅤ -FIP and gtr Ⅴ -BIP, the nucleotide sequences of which are shown in SEQ ID NOs. 29 to 32; For detection of Shigella flexneri oac LAMP primers for genes include oac -F3, oac -B3, oac -FIP and oac -BIP, whose nucleotide sequences are shown in SEQ ID NOs.45-48.
2. The LAMP primer set according to claim 1, It is characterized in that For detection of Shigella flexneri gtrⅠ LAMP primers for genes also include: loop primers gtrⅠ -LF and gtrⅠ -LB, whose nucleotide sequences are shown in SEQ ID NO.5-6; and / or, for detection of Shigella flexneri gtrIc LAMP primers for genes also include: loop primers gtrIc -LF, the nucleotide sequence of which is shown in SEQ ID NO.11; and / or, for detection of Shigella flexneri oac LAMP primers for genes also include: loop primers oac -LF and loop primers oac -LB, the nucleotide sequences of which are shown in SEQ ID NOs. 22-23; and / or, for detection of Shigella flexneri gtrⅣ LAMP primers for genes also include: loop primers gtrⅣ -LF, the nucleotide sequence of which is shown in SEQ ID NO.28; and / or, for detection of Shigella flexneri gtrⅤ LAMP primers for genes also include: gtrⅤ -LF and gtrⅤ -LB, whose nucleotide sequences are shown in SEQ ID NO.33-34; and / or, for detection of Shigella flexneri oac LAMP primers for genes also include: oac -LF, the nucleotide sequence of which is shown in SEQ ID NO.
49.
3. The LAMP primer set for detecting Shigella flexneri serotype according to claim 1 or 2, It is characterized in that Also included is the detection of Shigella flexneri gtrII , gx and opt LAMP primers for genes, For detection of Shigella flexneri gtrII LAMP primers for genes include gtrII -F3, gtrII -B3, gtrII -FIP and gtrII -BIP, the nucleotide sequences are shown in SEQ ID NOs. 12 to 15; For detection of Shigella flexneri gx LAMP primers for genes include gx -F3, gx -B3, gx -FIP and gx -BIP, the nucleotide sequences are shown in SEQ ID NOs. 35 to 38; For detection of Shigella flexneri opt LAMP primers for genes include opt -F3, opt -B3, opt -FIP and opt -BIP, the nucleotide sequences are shown in SEQ ID NOs. 40 to 43.
4. The LAMP primer set for detecting Shigella flexneri serotype according to claim 3, It is characterized in that For detection of Shigella flexneri gtrII LAMP primers for genes also include: loop primers gtrII -LF and gtrII -LB, whose nucleotide sequences are shown in SEQ ID NO.16-17; and / or, for detection of Shigella flexneri gx LAMP primers for genes also include: loop primers gx -LF, the nucleotide sequence of which is shown in SEQ ID NO.39; and / or, for detection of Shigella flexneri opt LAMP primers for genes also include: loop primers opt -LB, the nucleotide sequence of which is shown in SEQ ID NO.
44.
5. A detection reagent or kit comprising the LAMP primer set according to any one of claims 1 to 4.
6. Use of the LAMP primer set according to any one of claims 1 to 4, or the reagent or kit according to claim 5 in detecting Shigella flexneri serotypes, wherein the use is for non-disease diagnosis and treatment purposes.
7. Methods for detecting serotypes of Shigella flexneri, It is characterized in that The following steps are involved: 1) Extracting DNA from the sample to be tested; 2) using the DNA extracted in step 1) as a template, and performing a LAMP amplification reaction using the LAMP primer set according to any one of claims 1 to 4; 3) Determination of amplification results; The method is for non-disease diagnosis and treatment purposes.
8. The method for detecting Shigella flexneri serotype according to claim 7, It is characterized in that Step 2) The LAMP amplification reaction system is calculated as a 20 μL reaction system, including 10 μL 2X Bca BEST Buffer, primer mixture 1.5 μL, 8U / μl Bca BEST DNA Polymerase ver.2.0 0.4 μL, hydroxynaphthol blue 2 μL and DNA template 2 μL, finally supplemented to 20 μL with sterile water; in the primer mixture, the concentration of FIP and BIP primers is 40 pmol each, the concentration of F3 and B3 primers is 10 pmol each, and the concentration of LF and / or LB primers is 20 pmol each.
9. The method for detecting Shigella flexneri serotype according to claim 7 or 8, It is characterized in that Step 2) The conditions of the LAMP amplification reaction are 61° C., 40 min.
10. The method for detecting Shigella flexneri serotype according to any one of claims 7 to 9, It is characterized in that Step 3) Use any of the following methods ① to ③ to determine the amplification results: ①Observe the color change with naked eyes: After the amplification reaction is completed, the amplification of the target gene is determined based on the color change of the reaction system before and after the reaction; ② Agarose gel electrophoresis: If the amplified product shows characteristic ladder-like bands on the agarose gel, it indicates that the sample to be tested contains the target gene; ③ Magnesium pyrophosphate turbidity detection method: Use a turbidity meter to detect its absorbance at 400nm, and a turbidity greater than 0.1 is positive.
